Track topics on Twitter Track topics that are important to you
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2018 on Thursday, April 26, 2018. During a conference call at 10:30 a.m. EDT on April 26, company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 323-794-2093 or international 866-548-4713, confirmation code: 4713257. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:30 p.m. EDT on April 26 through 1:30 p.m. EDT on, May 10, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 4713257.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.
Bristol-Myers Squibb Company
Ken Dominski, 609-252-5251
Lisa McCormick Lavery, 609-252-7602
John Elicker, 609-252-4611
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...